Company Filing History:

11 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharpe & Dohme Corp.

patents

Years Active: 1997-2000

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6156787 - Substituted thienlycyclohexanone derivatives for enhancing cognition (2000-12-05),

2. 6156761 - Substituted tetralone derivatives for enhancing cognition (2000-12-05),

3. 6143773 - Substituted thienobenzisoxazole derivatives for enhancing cognition (2000-11-07),

4. 6048859 - Morpholine and thiomorpholine tachykinin receptor antagonists (2000-04-11),

5. 5998415 - Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues (1999-12-07),

6. 5981529 - Substituted indolylpropyl-piperazine derivatives as 5-HT.sub.1D .alpha. (1999-11-09),

7. 5973156 - Piperidine and tetrahydropyridine derivatives (1999-10-26),

8. 5925638 - Substituted 1-indolylpropyl-4-benzylpiperazine derivatives (1999-07-20),

9. 5919783 - Indoline and azaindoline derivatives as 5-HT.sub.1D alpha receptor (1999-07-06),

10. 5854268 - Azetidine, pyrrolidine and piperidine derivatives (1998-12-29),

11. 5849746 - Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT.sub.1D (1998-12-15),

12. 5807857 - Piperazine, piperidine and tetrahydropyridine derivative of (1998-09-15),

13. 5719147 - Morpholine and thiomorpholine tachykinin receptor antagonists (1998-02-17),

14. 5604240 - Pyrrolo-pyridine derivatives (1997-02-18),

Title: Mark Stuart Chambers: Innovator in Cognitive Enhancement

Introduction

Mark Stuart Chambers is a notable inventor based in Puckeridge, GB. He has made significant contributions to the field of cognitive enhancement, holding a total of 14 patents. His work focuses on developing compounds that can potentially improve cognitive functions, particularly in relation to diseases such as Alzheimer's.

Latest Patents

Chambers' latest patents include innovative compounds aimed at enhancing cognition. One of his notable inventions is a series of substituted tetralone derivatives, which are designed to provide therapeutic benefits for cognitive enhancement. The invention details a compound of formula (I) or a pharmaceutically acceptable salt thereof, with specific structural components defined in the disclosure. Another significant patent involves substituted thienylcyclohexanone derivatives, which also aim to enhance cognitive functions. These compounds are characterized by their unique structural formulas and potential applications in therapy.

Career Highlights

Throughout his career, Mark Stuart Chambers has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Merck & Co., Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cognitive enhancement.

Collaborations

Chambers has collaborated with several professionals in his field, including Sarah Christine Hobbs and Leslie Joseph Street. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Mark Stuart Chambers is a distinguished inventor whose work in cognitive enhancement has the potential to impact the treatment of cognitive diseases significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com